Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(594/week)
Manufacturing
(436/week)
Energy
(328/week)
Technology
(473/week)
Other Manufacturing
(362/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Center for Drug Evaluation and Research
Oct 15, 2018
Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA's new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies
Oct 08, 2018
FDAnews Announces The CDER Reorganization: What It Means for Drugmakers Webinar, Oct. 18, 2018
Oct 05, 2018
FDAnews Announces -- Quality Metrics Redux: Taking Advantage of FDA's Renewed Focus Webinar, Oct. 17, 2018
Sep 13, 2018
FDA approves new kind of treatment for hairy cell leukemia
Aug 30, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA's ongoing investigation into valsartan impurities and recalls and an update on FDA's current findings
Aug 08, 2018
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
Jul 12, 2018
Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA's efforts to advance long-term solutions to prevent shortages
Jun 21, 2018
CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol
Jun 19, 2018
Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA's Center for Drug Evaluation and Research, on the agency's response to ongoing drug shortages for critical products
Jun 12, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
May 31, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities
Apr 24, 2018
Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA's Fiscal Year 2019 budget
Apr 17, 2018
Remarks from FDA Commissioner Scott Gottlieb, M.D., on Fiscal Year 2019 budget request for FDA
Mar 06, 2018
WuXi Biologics Congratulates TaiMed on FDA Approval for Trogarzo
Feb 15, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA's new drug review programs
Feb 14, 2018
FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint
Jan 16, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs
Jan 14, 2018
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer
Jan 03, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices
Dec 21, 2017
FDA approves drug to treat dangerously low blood pressure
‹‹
Page 3
››
Latest News
May 3, 2024
BW LPG: Information about the proposed redomiciling to Singapore – Distribution of Practice Statement Letter
May 3, 2024
SenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 3, 2024
ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024
May 3, 2024
RTX Board of Directors Increases Quarterly Cash Dividend
May 3, 2024
Sandstorm Gold Royalties Announces Sale of Select Non-Core, Non-Precious Metals Assets and Renews Normal...
May 3, 2024
QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2024 RESULTS
May 3, 2024
Kimberly-Clark Declares Quarterly Dividend
May 3, 2024
MasTec Announces First Quarter 2024 Financial Results and Raises Guidance for the Year
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events